Research Article Open Access Double-Blind Peer Review

SELF-STIGMA AND ITS INFLUENCE ON EMPLOYMENT PROSPECTS FOR INDIVIDUALS LIVING WITH SCHIZOPHRENIA

Alexandra Papadopoulos·Andreas Nikolaou·Maria Ioannou
Published 31 January 2025
Vol. 12, No. 4 (2024)
pp. 34-50
CC BY 4.0
  1. 1
    Alexandra Papadopoulos
    Occupational therapist, Psychiatric Hospital of Attica, Greece.
    GR
  2. 2
    Andreas Nikolaou
    Hellenic Open University, Greece.
    GR
  3. 3
    Maria Ioannou
    Department of Psychology, University of Crete, Gallos’ University Campus, Rethymno, 74100, Greece
    GR

Mental illnesses encompass a spectrum of symptoms affecting cognition, emotion, communication, and behavior, with schizophrenia being a severe example leading to self-stigmatization and reduced self-esteem. Scientific advancements have revolutionized psychiatric treatment by introducing various psychopharmaceuticals, facilitating the deinstitutionalization of mentally ill individuals. Chlorpromazine's discovery in 1950 was a significant milestone in schizophrenia treatment, contributing to community living. However, successful reintegration into daily life depends on numerous factors beyond medication. This article examines the multifaceted aspects of living with schizophrenia in the post-asylum era and highlights the complex nature of recovery.

JournalApplied Psychology, Sociology, and Social Policy Journal
ISSN2998-8411
Volume / IssueVol. 12, No. 4 (2024)
Pages34-50
Published31 January 2025
DOI10.5281/zenodo.14779292
Access Open Access
LicenseCC BY 4.0 — reuse with attribution
PublisherKeith Publications
Papadopoulos, A., Nikolaou , A., Ioannou, M. (2025). SELF-STIGMA AND ITS INFLUENCE ON EMPLOYMENT PROSPECTS FOR INDIVIDUALS LIVING WITH SCHIZOPHRENIA. Applied Psychology, Sociology, and Social Policy Journal, Vol. 12 No. 4, pp. 34-50. DOI: https://doi.org/10.5281/zenodo.14779292

 Submit Your Research to Applied Psychology, Sociology, and Social Policy Journal

We invite original research articles, review papers, and case studies. Benefit from rigorous double-blind peer review, rapid decision within 4–8 weeks, DOI for every article, and worldwide open-access distribution.